Zyus Life Sciences

Zyus Life Sciences company information, Employees & Contact Information

ZYUS (TSXV: ZYUS) is a life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management. Through rigorous scientific exploration and clinical research, ZYUS aims to secure intellectual property protection, safeguarding its innovative therapies and bolstering shareholder value. ZYUS’ unwavering commitment extends to obtaining regulatory approval of non-opioid-based pharmaceutical solutions, in pursuit of transformational impact on patients’ lives. ZYUS: Advancing the Science of Well-Being.

Company Details

Employees
54
Founded
-
Address
204-407 Downey Rd, Saskatoon,saskatchewan S7n 4l8,canada
Phone
(306) 242-2357
Email
in****@****yus.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
zyus.com
HQ
Saskatoon, Saskatchewan
Looking for a particular Zyus Life Sciences employee's phone or email?

Zyus Life Sciences Questions

News

ZYUS Life Sciences Corporation Announces Closing of Secured Loan and Amendments to Prior Secured Promissory Note - Yahoo! Finance Canada

ZYUS Life Sciences Corporation Announces Closing of Secured Loan and Amendments to Prior Secured Promissory Note Yahoo! Finance Canada

ZYUS Life Sciences Activates First Clinical Site and Enrolls First Patient in Phase 2a UTOPIA-1 Cancer Pain Trial - PR Newswire

ZYUS Life Sciences Activates First Clinical Site and Enrolls First Patient in Phase 2a UTOPIA-1 Cancer Pain Trial PR Newswire

ZYUS Life Sciences Announces Closing of First Tranche of Unit Offering - Business Wire

ZYUS Life Sciences Announces Closing of First Tranche of Unit Offering Business Wire

ZYUS Life Sciences Announces Activation of Two Additional Clinical Sites in Phase 2a UTOPIA-1 Cancer Pain Trial - Seeking Alpha

ZYUS Life Sciences Announces Activation of Two Additional Clinical Sites in Phase 2a UTOPIA-1 Cancer Pain Trial Seeking Alpha

ZYUS Life Sciences Strengthens Clinical Leadership with Appointment of Chief Medical Officer to Support Phase 2 Oncology Pain Trial - Business Wire

ZYUS Life Sciences Strengthens Clinical Leadership with Appointment of Chief Medical Officer to Support Phase 2 Oncology Pain Trial Business Wire

ZYUS Life Sciences Finalizing Site Initiation for Phase 2A Clinical Trial Advancing Novel Non-Opioid Pain Drug - BioSpace

ZYUS Life Sciences Finalizing Site Initiation for Phase 2A Clinical Trial Advancing Novel Non-Opioid Pain Drug BioSpace

Several Insiders Invested In ZYUS Life Sciences Flagging Positive News - simplywall.st

Several Insiders Invested In ZYUS Life Sciences Flagging Positive News simplywall.st

ZYUS Life Sciences Secures Additional Funding to Advance Drug Development - TipRanks

ZYUS Life Sciences Secures Additional Funding to Advance Drug Development TipRanks

BRENT H. ZETTL PROVIDES UPDATE ON HOLDINGS OF ZYUS LIFE SCIENCES CORPORATION - Yahoo Finance

BRENT H. ZETTL PROVIDES UPDATE ON HOLDINGS OF ZYUS LIFE SCIENCES CORPORATION Yahoo Finance

ZYUS Life Sciences Secures $1.5 Million Loan, Boosts Investor Stake - TipRanks

ZYUS Life Sciences Secures $1.5 Million Loan, Boosts Investor Stake TipRanks

ZYUS Life Sciences CEO Increases Stake Through Strategic Warrant Issuance - TipRanks

ZYUS Life Sciences CEO Increases Stake Through Strategic Warrant Issuance TipRanks

ZYUS Life Sciences Initiates Phase 2a Cancer Pain Trial with Trichomylin® - TipRanks

ZYUS Life Sciences Initiates Phase 2a Cancer Pain Trial with Trichomylin® TipRanks

ZYUS enrolls first patient in phase 2a cancer pain trial - Investing.com

ZYUS enrolls first patient in phase 2a cancer pain trial Investing.com

ZYUS Life Sciences Secures Loan and Amends Promissory Note - TipRanks

ZYUS Life Sciences Secures Loan and Amends Promissory Note TipRanks

Zyus Life Sciences Advances Cancer Pain Treatment with Trichomylin® Study - TipRanks

Zyus Life Sciences Advances Cancer Pain Treatment with Trichomylin® Study TipRanks

ZYUS Life Sciences Corporation announced that it has received funding - MarketScreener

ZYUS Life Sciences Corporation announced that it has received funding MarketScreener

Zyus Life Sciences Corporation Announces Closing of Additional Secured Loan - MarketScreener

Zyus Life Sciences Corporation Announces Closing of Additional Secured Loan MarketScreener

Phoenix Canada Oil Company Limited Announces Successful Close of Subscription Receipt Financing Required for Reverse Takeover Transaction with ZYUS Life Sciences Inc. and Record Date for Warrant Distribution - Yahoo Finance

Phoenix Canada Oil Company Limited Announces Successful Close of Subscription Receipt Financing Required for Reverse Takeover Transaction with ZYUS Life Sciences Inc. and Record Date for Warrant Distribution Yahoo Finance

Cannabis Maker Zyus to Go Public in Reverse Merger With Oil Producer Phoenix - Bloomberg

Cannabis Maker Zyus to Go Public in Reverse Merger With Oil Producer Phoenix Bloomberg

ZYUS Life Sciences Corporation completes RTO - Borden Ladner Gervais LLP (BLG)

ZYUS Life Sciences Corporation completes RTO Borden Ladner Gervais LLP (BLG)

Cannabis producers Pure Sunfarms, Zyus receive EU-GMP certification - MJBizDaily

Cannabis producers Pure Sunfarms, Zyus receive EU-GMP certification MJBizDaily

ZYUS Life Sciences Secures Additional Funding to Advance Drug Development - MSN

ZYUS Life Sciences Secures Additional Funding to Advance Drug Development MSN

Zyus to develop plant-based vaccine for COVID-19 - BioSpectrum Asia

Zyus to develop plant-based vaccine for COVID-19 BioSpectrum Asia

Top Zyus Life Sciences Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant